Search
for
Sort by
Research 901–930 of 1000+
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Subject Index
- Mechanistic synergy of hair growth promotion by the Avicennia marina extract and its active constituent (avicequinone C) in dermal papilla cells isolated from androgenic alopecia patients
- Pregnancy and the Skin
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Dermatology and Pregnancy
- Association of DNA damage with vitamin D and hair heavy metals of obese women
- Hormonal Treatment for Skin Androgen-Related Disorders
- Hyperadrenocorticism in Ferrets
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Hormonal Therapy for Acne
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Nonclassic Congenital Adrenal Hyperplasia
- Safety of testosterone use in women
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Relating neurosteroid modulation of inhibitory neurotransmission to behaviour
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Association of vitamin D level with alopecia areata
- The role of androgen therapy
- Estrogen modulates mesenchymal-epidermal interactions in the adult nipple
- Crystallization and preliminary X-ray analysis of the human androgen receptor ligand-binding domain with a coactivator-like peptide and selective androgen receptor modulators
- Plasmaproteinbindung endogener Glucocorticosteroide und deren Einfluss auf Haar- und Speichelkonzentrationen
- Androgen Treatment in Women
- Insulin Resistance and Polycystic Ovary Syndrome
- Estrogens and aging skin
- Hair Loss in Women
- Biology of Hair Growth
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?